Literature DB >> 25439382

Telangiectasia macularis eruptiva perstans or highly vascularized urticaria pigmentosa?

Kelli W Williams1, Dean D Metcalfe2, Calman Prussin2, Melody C Carter2, Hirsh D Komarow3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25439382      PMCID： PMC4254445          DOI： 10.1016/j.jaip.2014.07.002

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  10 in total

1.  Urticaria pigmentosa; mastocytosis; a consideration of various manifestations.

Authors:  W R NICKEL
Journal:  AMA Arch Derm       Date:  1957-10

2.  Telangiectasia Macularis Eruptiva Perstans-probably a telangiectatic variety of urticaria pigmentosa in an adult.

Authors:  F P Weber
Journal:  Proc R Soc Med       Date:  1930-12

3.  Telangiectasia macularis eruptiva perstans: a rare form of adult mastocytosis.

Authors:  Dailana Louvain Marinho Costa; Heloisa Helena Moura; Rosangela Rodrigues; Juan Pineiro-Maceira; Marcia Ramos-E-Silva
Journal:  J Clin Aesthet Dermatol       Date:  2011-10

4.  Treatment of telangiectasia macularis eruptiva perstans with montelukast.

Authors:  R Cengizlier; S Hücümenoğlu; A Ozen; R Tülin Sayli
Journal:  Allergol Immunopathol (Madr)       Date:  2009 Nov-Dec       Impact factor: 1.667

Review 5.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

Review 6.  Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Authors:  P Valent; H P Horny; L Escribano; B J Longley; C Y Li; L B Schwartz; G Marone; R Nuñez; C Akin; K Sotlar; W R Sperr; K Wolff; R D Brunning; R M Parwaresch; K F Austen; K Lennert; D D Metcalfe; J W Vardiman; J M Bennett
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

Review 7.  The skin in mastocytosis.

Authors:  N A Soter
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

Review 8.  Diagnostic criteria and classification of mastocytosis in 2014.

Authors:  Cem Akin; Peter Valent
Journal:  Immunol Allergy Clin North Am       Date:  2014-05       Impact factor: 3.479

9.  Telangiectasia macularis eruptive perstans successfully treated with PUVA therapy.

Authors:  Eleni Sotiriou; Zoi Apalla; Demetris Ioannides
Journal:  Photodermatol Photoimmunol Photomed       Date:  2010-02       Impact factor: 3.135

Review 10.  Telangiectasia macularis eruptiva perstans: a case report and review of the literature.

Authors:  R P Sarkany; B E Monk; S E Handfield-Jones
Journal:  Clin Exp Dermatol       Date:  1998-01       Impact factor: 3.470
  10 in total
  1 in total

1.  Primary cicatricial alopecia associated with systemic indolent mastocytosis.

Authors:  Sonya Prasad; Brianna De Souza; Laura J Burns; Maryanne M Senna
Journal:  JAAD Case Rep       Date:  2020-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.